|
Mo Y-Y, Yu Y, Shen Z, Beck WT. 2002. Nucleolar delocalization of human topoisomerase I in response to topotecan correlates with sumoylation of the protein. J Biol Chem.277:2958-64.
Tavormina PA, Come MG, Hudson JR, Mo Y-Y, Beck WT, Gorbsky GJ. 2002. Rapid exchange of mammalian topoisomerase II{alpha}at kinetochores and chromosome arms in mitosis. J. Cell Biol. 158:23-29.
Rallabhandi P, Hashimoto K, Mo YY, Beck WT, Moitra PK, D'Arpa P. 2002. Sumoylation of topoisomerase I is involved in its partitioning between nucleoli and nucleoplasm and its clearing from nucleoli in response to camptothecin. J Biol Chem. 277:40020-40026.
Mo, Y-Y, Yu Y, Ee P.P., Beck, W.T. 2004. Overexpression of a dominant negative mutant Ubc9 is associated with increased sensitivity to anticancer drugs, Cancer Research, 64(8):2793-8
Mo, Y-Y, Yu Y, Theodosio E., Ee P.P., Beck, W.T. 2005. A role for Ubc9 in tumorigenesis. Oncogene. 24:2677-83.
Anh Dinh, Mo, Y-Y. 2005. An alternative approach to generating shRNAs from cDNAs. Biotechniques. 38:629-632.
Mo, Y-Y., Moschos, S. 2005. Targeting Ubc9 for cancer therapy. Expert Opinion on Therapeutic Targets. 9:1203-16.
Lu Z, Wu H, Mo YY. 2006. Regulation of bcl-2 expression by Ubc9. Experimental Cell Research. 2006 Mar 25; [Epub ahead of print]
Wu F, Mo, Y-Y. 2006. Ubiquitin-like protein modifications in prostate and breast cancer. Frontier in Bioscience. In press.
Moschos SJ, Mo YY 2006. Role of Ubc9 in DNA damage repair and tumorigenesis. J Mol Histol. Jun 7; [Epub ahead of print].
3.
Dinh, A., Mo, Y-Y. 2005. An alternative approach to
generating shRNAs from cDNAs. Biotechniques. 38:629-632.
Mo, Y-Y, Yu Y, Theodosio E., Ee P.P., Beck, W.T.
2005. A role for Ubc9 in tumorigenesis. Oncogene.
24:2677-83.
Mo, Y-Y, Yu Y, Ee P.P., Beck, W.T. 2004. Overexpression
of a dominant negative mutant Ubc9 is associated with
increased sensitivity to anticancer drugs, Cancer
Research, 64(8):2793-8
Rallabhandi P, Hashimoto K, Mo Y-Y, Beck WT, Moitra
PK, D'Arpa P. 2002. Sumoylation of topoisomerase I
is involved in its partitioning between nucleoli and
nucleoplasm and its clearing from nucleoli in response
to camptothecin. J Biol Chem. 277:40020-6.
Tavormina PA, Come MG, Hudson JR, Mo Y-Y, Beck
WT, 2002. Gorbsky GJ. Rapid exchange of mammalian
topoisomerase II{alpha}at kinetochores and chromosome
arms in mitosis. J. Cell Biol. 158:23-29.
Mo, Y-Y, Yu, Y-N, Shen, Z. and Beck, W.T. 2002.
Sumoylation of topoisomerase I in response to topotecan
is associated with its nucleolar delocalization J.
Biol. Chem. 277:2958-2964.
Zhang, JH, Barr VA, Mo, Y-Y, Rojkova, AM, Liu,
S, Simonds, WF. 2001. Nuclear localization of G protein
beta 5 and regulator of G protein signaling 7 in neurons
and brain. J. Biol. Chem. 276:10284-10289.
Mo, Y-Y, Wang C., and Beck, W.T. 2000. A novel
nuclear localization sequence in human DNA topoisomerase
I. J. Biol. Chem. 275:41107-41113
Yu R, Chen C, Mo Y-Y, Hebbar V, Owuor ED, Tan
TH, and Kong AN. 2000. Activation of Mitogen-activated
Protein Kinase Pathways Induces Antioxidant Response
Element-mediated Gene Expression via Nrf2-dependent
Mechanism. J. Biol. Chem. 275:39907-39913
Mo, Y-Y., Wang, P., and Beck, W.T. 2000. Functional
expression of human topoisomerase I fused to enhanced
green fluorescent protein in mammalian cells. Exp.
Cell. Res. 256:480-490. |
